SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-24-004916
Filing Date
2024-07-17
Accepted
2024-07-17 16:58:49
Documents
1
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4076
  Complete submission text file 0001683168-24-004916.txt   5735
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Issuer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ATRINSIC, INC. 1 GRAND CENTRAL PLACE SUITE 2319 NEW YORK NY 10165
Business Address
SCHECHTER JONATHAN (Reporting) CIK: 0001619259 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40699 | Film No.: 241122808